STIMULATE-ICP Trial

The trial component of STIMULATE-ICP aims to recruit over 1200 people with Long Covid, across a number of Long Covid Clinics throughout England and Scotland. More detail is available in the trial protocol, which can be accessed through this link: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0272472 (PLOS ONE)

In order to inform a new integrated care pathway for people with Long Covid, the study is evaluating:

• Current Care
• Comprehensive MRI scan (using CoverscanTM developed by Perspectum)
• Enhanced rehabilitation (Living with COVID RecoveryTM developed by Living With) 

Within this study, another trial is testing different drugs to measure effects of three months treatment on symptoms, mental health, return to work and other important outcomes. You can find out more about the drugs being tested via this link: https://www.stimulate-icp.org/faq 

Please note that the trial is no longer accepting new participants; we aim to share findings in early 2025.